Ethnobotany is the scientific study of how human cultures perceive, classify, use and manage plants. It is the oldest and most enduring foundation of herbal medicine and natural product discovery. Long before the emergence of phytochemistry or pharmacology, human societies developed sophisticated medicinal plant systems through empirical observation, cultural transmission and ecological adaptation.
       
Today, approximately 80% of the global population relies on herbal medicine for primary healthcare (WHO, 2020). More than 60% of modern pharmaceuticals originate from natural products, many of which were first identified through traditional knowledge (Newman and Cragg, 2020). Ethnobotany provides a culturally grounded rationale for plant selection, a predictive framework for bioactivity and a holistic understanding of therapeutic context.
       
This review positions ethnobotany not as a historical precursor but as the central conceptual framework for herbal and natural product research. The major research gaps are:
       
Ethnobotany remains the cornerstone of herbal and natural product research, yet significant gaps persist in integrating traditional knowledge with modern multi omics, ensuring reproducibility and addressing sustainability. The most urgent need is to bridge indigenous wisdom with advanced analytical and computational tools to accelerate discovery while protecting biodiversity (Albuquerque et al., 2017; Chele et al., 2025).
 
Major research gaps
 
• Plant selection bias: Reliance on traditional use often overlooks plants with untapped bioactivity, leaving many species underexplored due to cultural or geographic limitations (Soejarto et al., 2005).
•​ Data integration challenges: Multi omics datasets remain fragmented and poorly linked to ethnobotanical records (Karalija et al., 2025).
•​ Loss of bioactivity in isolation: Conventional fractionation methods ignore synergistic effects present in traditional formulations (Chele et al., 2025).
•​ Rediscovery problem:  Workflows often repeatedly identify known compounds due to limited prioritization strategies (Damle et al., 2022).
•​ Authentication and quality control: Misidentification and lack of standardized repositories hinder reproducibility (Devi and Khare, 2026; Masand and Thakur, 2026).
•​ Ethical and sustainability concerns: Overharvesting threatens biodiversity, while benefit sharing with indigenous communities remains inadequate (Thirupathi, 2026; EVS Institute, 2025).
 
Specific objectives
 
•​ Document ethnobotanical methodologies: Critically analyze documentation methods (field surveys, oral histories, participatory approaches) for reliability in modern research (Mulani and Bhole, 2026).
 
•​ Map global ethnobotanical knowledge: Identify regions rich versus underrepresented in ethnobotanical data to prioritize exploration (Damle et al., 2022).
 
•​ Integrate omics with ethnobotany: Assess how genomics, metabolomics and proteomics validate or expand traditional knowledge (Chele et al., 2025; Karalija et al., 2025).
 
•​ Evaluate compound discovery efficiency: Compare ethnobotany guided discovery rates against random or high throughput screening (Albuquerque et al., 2017; Soejarto et al., 2005).
 
•​ Analyze synergistic formulations: Investigate traditional multi plant remedies to inform systems pharmacology (Chele et al., 2025).
 
•​ Address reproducibility and authentication: Propose standardized protocols using DNA barcoding and voucher specimens (Devi and Khare, 2026; Masand and Thakur, 2026).
 
•​ Explore ethical frameworks: Review benefit sharing models, IP rights and conservation strategies for equitable practices (Thirupathi, 2026; EVS Institute, 2025).
       
They translate broad themes into actionable research questions, bridge traditional knowledge with modern science and highlight reproducibility, ethics and sustainability all critical for long term credibility.
       
This review article, completed in 2026, synthesises contemporary and classical scholarship to examine the ethnobotanical foundations of herbal and natural product research. The objective of the review is to critically analyse how ethnobotanical knowledge systems inform plant selection, therapeutic interpretation, cultural context and ecological understanding, thereby highlighting ethnobotany as the central framework guiding modern natural product discovery (review objective). The significance of this work lies in its integration of biocultural, phytochemical and pharmacological perspectives, demonstrating how traditional knowledge continues to shape scientific inquiry, conservation priorities and ethical research practices (Heinrich, 2015; Maffi, 2005).
       
The literature base for this review was systematically assembled to ensure both breadth and depth with consulting journals, ethnobotanical monographs, pharmacognosy texts and global policy documents. Key sources include Journal of Ethnopharmacology, Economic Botany, Phytochemistry Reviews and foundational works in ethnobotany, ethnopharmacology and biocultural conservation (literature sources). Searches were conducted across Scopus, Web of Science, PubMed and Google Scholar, using combinations of ethnobotany, ethnopharmacology, biocultural diversity, phytochemistry and conservation as keywords. Boolean operators and controlled vocabulary terms were applied to refine results.
 
•​ Inclusion criteria: Peer reviewed articles, ethnobotanical monographs, pharmacognosy texts and global policy documents published between 1995-2026, supplemented with classical ethnobotanical works where historically relevant.
 
•​ Exclusion criteria: Non peer reviewed sources, anecdotal accounts without methodological rigor and studies lacking cultural or ecological context.
 
•​ Critical synthesis: Literature was not only catalogued but evaluated for methodological robustness, cultural specificity and translational relevance. This allowed identification of gaps in ethnopharmacological validation and conservation frameworks.
       
The review discusses several major aspects, including:
 
•​ Historical foundations of ethnobotany, tracing intellectual lineages across global medical traditions.

•​ Ethnobotanical methods and analytical approaches, covering qualitative and quantitative tools.
 
•​ Cultural pharmacopoeias and biocultural knowledge systems, emphasising cultural specificity and ecological adaptation.
 
•​ Ethnobotany driven plant selection, highlighting cross cultural convergence and phytochemical relevance.
 
•​ Traditional preparation methods, with attention to extraction chemistry and bioavailability.
 
•​ Ethnopharmacological validation, linking traditional claims to laboratory evidence.
 
•​ Safety frameworks, integrating traditional toxicity knowledge with modern pharmacovigilance.
 
· Biocultural diversity and conservation, addressing community rights, sustainability and benefit sharing.
 
•​ Case studies of ethnobotanical success, demonstrating the translational power of traditional knowledge.
       
These thematic components collectively establish ethnobotany as a multidissciplinary, culturally grounded and scientifically indispensable field that continues to guide natural product research and global health innovation (ethnobotany significance).
 
Historical foundations of ethnobotany
 
Ethnobotany’s historical foundations lie in a long continuum of plant knowledge traditions that predate its formal naming by Harshberger in 1895 (Harshberger). In Ayurveda, India’s classical medical system, more than 3,000 medicinal plants were codified in canonical texts such as the Charaka Samhita and Sushruta Samhita, reflecting a sophisticated pharmacological tradition (Balick and Cox, 1996; Mukherjee, 2019). Similarly, Traditional Chinese Medicine, with over 2,500 years of documented materia medica, systematised botanical therapeutics in works like the Shennong Bencao Jing (Unschuld, 1986; Heinrich et al., 2023). The Greco Arab Unani tradition integrated Hippocratic and Galenic humoral theory with Arab-Islamic herbal scholarship, culminating in influential pharmacopeias such as Ibn Sina’s Canon of Medicine (Levey, 1966). Across continents, Indigenous knowledge systems preserved ecological and medicinal plant expertise through oral transmission, ritual practice and ecosystem specific stewardship, forming some of the world’s oldest continuous ethnobotanical archives. Bisen et al. (2025) documented 35 medicinal plant species used by Baiga and Gond tribes, detailing plant habits, traditional uses and intake methods. It provides strong ethnobotanical evidence for indigenous knowledge systems as foundational to herbal research. However, Sharma et al. (2021) documented 68-79 medicinal plant species used by local communities, emphasizing ethnomedicine’s role in primary healthcare and drug discovery-ideal for your manuscript’s historical and methodological sections. In medieval Europe, monastic herbals and pharmacopeias contributed to early Western botanical science and laid groundwork for later taxonomic traditions. Together, these diverse knowledge systems constitute the millennia long intellectual lineage from which modern ethnobotany emerged, demonstrating that the discipline’s scientific formalisation rests upon deeply rooted cultural, medical and ecological traditions (ethnobotany). Ananda Kumar et al. (2023) in your paper highlights sacred groves as biodiversity reservoirs containing medicinal, endemic and endangered species. It supports your manuscript’s argument that ethnobotany informs conservation-driven natural product discovery.
 
Ethnobotanical methods and approaches
 
Ethnobotanical research integrates a suite of qualitative and quantitative approaches that together enable rigorous, culturally grounded documentation of plant knowledge. Core qualitative techniques include semi structured interviews, which elicit detailed narratives while allowing flexibility in respondent led discussion (Alexiades, 1996; Martin, 2004) and free listing, a method used to identify culturally salient species by analysing the order and frequency with which informants name plants (Quinlan, 2005). Participant observation and participatory rural appraisal deepen contextual understanding by embedding the researcher within daily practices, resource use and community decision making processes (participant observation; PRA). Quantitative tools such as use value indices, Informant Consensus Factor (ICF) and Fidelity Level (FL) allow systematic assessment of the relative importance, agreement and therapeutic specificity of medicinal species (Trotter and Logan, 1986; Friedman et al., 1986; Heinrich et al., 1998). More advanced analytical frameworks, including cultural consensus analysis, evaluate shared knowledge structures and the degree of agreement within cultural groups (cultural consensus). Together, these methods provide a robust, multi layered approach for identifying culturally significant plants, mapping therapeutic patterns and safeguarding traditional knowledge systems within a scientific framework.
 
Cultural pharmacopoeias and traditional knowledge systems
 
Cultural pharmacopoeias represent the accumulated medicinal plant knowledge of distinct societies, each shaped by its ecology, cosmology, ritual practices, symbolic systems and social organisation. These knowledge systems function as adaptive frameworks through which communities interpret health, illness and the therapeutic properties of plants (cultural pharmacopoeias). In Amazonian shamanic traditions, healing repertoires emerge from intimate forest ecology, visionary cosmologies and ritual specialists who mediate relationships between humans, plants and spirit worlds (Schultes and Raffauf, 1990; Luna, 1984). Aboriginal Australian bush medicine reflects tens of thousands of years of biocultural continuity, where plant use is embedded in Dreaming narratives, kinship structures and land based custodianship (Clarke, 2008). African traditional healing systems integrate herbalism with divination, ancestral veneration and community centred therapeutic roles, producing regionally distinct yet conceptually linked pharmacopoeias (van Wyk, 2008). In the Himalayan region, Tibetan Sowa Rigpa synthesises Buddhist cosmology, humoral theory and high altitude ethnobotanical expertise into a sophisticated medical corpus (Gyatso, 2015). Native American ethnomedicine similarly reflects ecological diversity and cultural specificity, with plant knowledge transmitted through oral tradition, ceremonial practice and clan based stewardship (Moerman, 1998). Across these traditions, cultural pharmacopoeias embody centuries of empirical refinement, ecological adaptation and culturally mediated experimentation, forming dynamic knowledge systems that continue to evolve within their social and environmental contexts.
 
Ethnobotany as a driver of plant selection
 
Ethnobotanical knowledge plays a decisive role in guiding plant selection for pharmacological investigation, with cross cultural patterns serving as strong predictors of biological activity. When multiple communities independently cite the same species for similar therapeutic uses, the probability of identifying bioactive secondary metabolites increases substantially (Heinrich, 2000; Fabricant and Farnsworth, 2001). Such convergence often corresponds to the presence of anti inflammatory flavonoids, antimicrobial terpenoids, antidiabetic alkaloids and hepatoprotective phenolics, compounds widely recognised for their pharmacodynamic relevance (bioactive compounds). Comparative ethnobotanical analysis demonstrates that plants repeatedly selected across cultures tend to exhibit measurable pharmacological effects, reflecting centuries of empirical refinement and culturally mediated experimentation. Consequently, cross cultural agreement functions as a powerful heuristic for prioritising species in drug discovery pipelines, bridging traditional knowledge systems with modern phytochemical and pharmacological research (cross cultural convergence).
 
Traditional preparation methods and their chemical implications
 
Traditional preparation techniques profoundly shape the phytochemical profile, bioavailability and therapeutic activity of medicinal plants. These methods developed through centuries of empirical refinement selectively extract, preserve, or transform specific classes of compounds, thereby influencing both efficacy and safety. Decoctions tend to concentrate polar phenolics, infusions retain volatile aromatics, macerations solubilise alkaloids and glycosides, fermentation enzymatically modifies glycosides and enhances absorption and smoke preparations volatilise terpenoids for rapid inhalational delivery. Understanding these preparation dependent chemical shifts is essential for accurate pharmacological interpretation and for bridging traditional practices with modern phytochemistry (traditional preparations).
       
Ethnopharmacological studies consistently show that preparation method is as important as species identity, since extraction chemistry determines which metabolites reach biologically relevant concentrations (Heinrich, 2015; Williamson et al., 2013).
 
Traditional preparation methods and their chemical implications
 
Traditional preparation methods exert strong control over the qualitative and quantitative composition of plant extracts. Decoctions, involving prolonged boiling, efficiently extract polar phenolics, tannins and water soluble flavonoids while degrading some heat labile constituents (Williamson et al., 2013). Infusions, prepared with hot but non boiling water, better preserve volatile compounds such as monoterpenes and aromatic esters, making them suitable for delicate flowers and leaves (Heinrich et al., 2009). Macerations, which rely on cold or room temperature solvent extraction, are particularly effective for alkaloids, glycosides and other moderately polar constituents that diffuse slowly from plant tissues (Bruneton, 1999). Fermentation introduces microbial and enzymatic transformations that can hydrolyse glycosides, reduce toxicity and enhance bioavailability, as seen in many Asian and African traditional medicines (Zhao et al., 2015). Smoke preparations, common in Indigenous pharmacopoeias, volatilise terpenoids and other lipophilic compounds, enabling rapid absorption through the respiratory tract and altering chemical profiles through pyrolysis (Adams, 2017). Collectively, these methods illustrate how traditional pharmaceutics function as sophisticated biochemical technologies, shaping therapeutic outcomes through controlled extraction and transformation processes.
 
Ethnopharmacology: laboratory validation of traditional knowledge
 
Ethnopharmacology provides the experimental framework through which traditional ethnobotanical knowledge is scientifically validated, linking cultural plant use with measurable biological activity. This interdisciplinary field employs in vitro assays, in vivo models, phytochemical profiling, toxicological evaluation and bioassay guided fractionation to test hypotheses generated from traditional claims (ethnopharmacology). In vitro assays allow rapid screening for antimicrobial, anti inflammatory, antioxidant, cytotoxic, or enzyme modulating effects, while in vivo models evaluate physiological relevance, pharmacokinetics and systemic safety (Heinrich, 2015; Calixto 2000). Phytochemical profiling using chromatographic and spectrometric techniques identifies the metabolites responsible for observed activity and toxicological evaluation ensures that traditional preparations fall within safe therapeutic margins (Williamson et al., 2013). Bioassay guided fractionation further isolates active compounds by iteratively linking chemical fractions to biological effects, a process central to natural product drug discovery (Hamburger and Hostettmann, 1991). Across numerous studies, ethnobotanical claims show strong correlation with experimentally verified bioactivity, demonstrating that traditional knowledge systems often encode empirically effective therapeutic strategies refined over generations (bioassay guided fractionation).
 
Cross cultural convergence in medicinal plant use
 
Cross cultural convergence in medicinal plant use provides one of the strongest empirical signals for pharmacological relevance, as independent cultural traditions often arrive at similar therapeutic applications for species containing bioactive metabolites. When multiple societies employ the same plant for comparable ailments, this pattern frequently reflects underlying anti inflammatory, antimicrobial, analgesic, or antipyretic activities encoded in their phytochemistry (cross cultural convergence). Classic examples include Curcuma longa, widely used across South and Southeast Asia for inflammation and now known to contain curcuminoids with anti inflammatory and antioxidant effects; Azadirachta indica, employed throughout South Asia and Africa for infections due to its rich profile of limonoids and antimicrobial terpenoids; Salix alba, used across Eurasia for pain relief and later shown to contain salicin, the precursor to aspirin; and Cinchona species, long used in Andean and global traditional medicine for fever, ultimately yielding quinine, a cornerstone antimalarial (Heinrich, 2000; Fabricant and Farnsworth, 2001). Such cross cultural agreement strengthens the rationale for scientific investigation (Table 1), demonstrating that traditional knowledge systems often converge on plants with demonstrable pharmacological activity (medicinal plant convergence). These will visually demonstrate how independent traditions converge on the same species and how phytochemistry validates their therapeutic claims.


 
Ethnobotany and safety assessment
 
Ethnobotanical knowledge systems incorporate sophisticated safety frameworks that have evolved through long term empirical observation, cultural regulation and intergenerational transmission. These frameworks encompass toxicity awareness, contraindications, dosage norms, preparation specific safety rules and ritual safeguards, all of which function to minimise harm and optimise therapeutic outcomes. Traditional healers often maintain detailed knowledge of toxic species, safe harvesting stages and antidotal plants, while contraindications-such as avoiding certain herbs during pregnancy or with specific illnesses are embedded in cultural teaching (Heinrich, 2015; Etkin, 1996). Dosage norms are calibrated through experience, often expressed through culturally specific units (pinches, leaves, gourds, cups) and preparation safety ensures that harmful constituents are neutralised through boiling, roasting, fermentation, or admixture with protective ingredients (ethnobotanical safety). In many societies, ritual safeguards including taboos, timing rules, or ceremonial protocols-serve both symbolic and practical protective functions, regulating access to potent plants and reinforcing careful handling. These traditional safety systems complement modern toxicology and pharmacovigilance, offering valuable insights into long term human–plant interactions and guiding contemporary assessments of herbal safety (traditional toxicity knowledge).
 
Biocultural diversity and conservation
 
Biocultural diversity forms the foundation upon which medicinal plant knowledge is created, transmitted and sustained. Such knowledge is deeply embedded in cultural identity, language, ritual practice and ecological stewardship, making it inseparable from the social and environmental contexts in which it evolves (biocultural diversity). As communities interact with their landscapes, they develop culturally specific pharmacopoeias that encode ecological insight, symbolic meaning and practical therapeutic experience. The erosion of cultural diversity through language loss, displacement, habitat degradation, or globalisation-directly threatens the continuity of medicinal plant knowledge, as each cultural system represents a unique repository of ethnobotanical expertise (Maffi, 2005; Posey, 1999).
       
Conservation strategies must therefore integrate community based resource management, sustainable harvesting, intellectual property rights and benefit sharing frameworks, ensuring that local knowledge holders remain central actors in stewardship and decision making (community management; benefit sharing). Community based approaches empower Indigenous and local groups to manage plant populations according to traditional ecological principles, while sustainable harvesting guidelines protect vulnerable species from overexploitation. Intellectual property and traditional knowledge protections such as sui generis systems, prior informed consent and access and benefit sharing agreements help safeguard cultural rights and ensure equitable outcomes in research and commercialisation (CBD, 2011; Dutfield, 2017). Together, these strategies recognise that conserving medicinal plants requires conserving the cultures, languages and landscapes that sustain them.
 
Case studies of ethnobotanical success
 
Ethnobotany has repeatedly demonstrated its value as a driver of major pharmaceutical breakthroughs, with several landmark drugs (Table 2) emerging directly from traditional knowledge systems. Artemisinin, derived from Artemisia annua in Traditional Chinese Medicine, revolutionised global malaria treatment after its rediscovery through ethnopharmacological investigation (Tu, 2011). Aspirin, inspired by European folk uses of Salix alba for pain and fever, led to the isolation of salicin and ultimately acetylsalicylic acid, one of the world’s most widely used medicines (Vane and Botting, 2003). Morphine, obtained from Papaver somniferum, reflects millennia of Middle Eastern and Mediterranean use of opium for analgesia, culminating in the isolation of morphine as the first modern alkaloid drug (Booth, 1996). Quinine, sourced from Cinchona species and rooted in Andean Indigenous knowledge, became the foundational antimalarial compound and shaped the history of tropical medicine (Newman and Cragg, 2016). These case studies illustrate how cross cultural empirical knowledge, when combined with laboratory science, yields transformative therapeutic innovations, underscoring the enduring scientific value of ethnobotanical traditions (ethnobotanical success).


                                                               
Future prospects of ethnobotany as the foundational framework for herbal and natural product research
 
The future of ethnobotany is defined by its expanding role as the core integrative framework linking cultural knowledge, biodiversity and scientific innovation. As global interest in natural medicines accelerates, ethnobotany will increasingly guide research priorities, ethical standards and biocultural conservation strategies, ensuring that medicinal plant discovery remains both scientifically rigorous and culturally grounded. Its prospects can be understood across several emerging trajectories.
 
Integration with advanced scientific technologies
 
Ethnobotany will increasingly intersect with genomics, metabolomics, AI assisted compound discovery and network pharmacology, enabling deeper exploration of traditional knowledge systems. High throughput screening and computational modelling will allow researchers to test ethnobotanical hypotheses with unprecedented precision, strengthening the link between cultural use patterns and molecular mechanisms (future technologies).
 
Strengthening biocultural conservation
 
As climate change and habitat loss accelerate, ethnobotany will play a central role in biocultural conservation, linking the protection of medicinal plants with the preservation of cultural identity, language and traditional ecological knowledge. Future conservation frameworks will increasingly rely on community led stewardship, sustainable harvesting protocols and benefit sharing agreements aligned with the Nagoya Protocol (biocultural conservation).
 
Ethical and equitable research models
 
The future of ethnobotany demands stronger ethical foundations, including:
•​ Prior informed consent
•​ Protection of traditional knowledge
•​ Fair and equitable benefit sharing
•​ Co authorship and co leadership with Indigenous communities
       
These models will redefine how natural product research is conducted, ensuring that cultural knowledge holders remain central partners rather than peripheral informants (ethical frameworks).
 
Expansion of cross cultural databases
 
Global digital platforms will allow the creation of cross cultural medicinal plant databases, integrating linguistic, ecological, phytochemical and ethnopharmacological data. Such resources will enhance comparative analysis, identify convergence patterns and accelerate the discovery of pharmacologically relevant species (cross cultural databases).
 
Revitalisation of traditional knowledge systems
 
Future ethnobotanical work will increasingly support:
•​ Cultural revitalisation programs
•​ Traditional healer networks
•​ Intergenerational knowledge transmission
•​ Community based education
       
These efforts will strengthen cultural resilience and ensure the continuity of medicinal plant knowledge in the face of globalisation and language loss.
 
Policy influence and global health integration
 
Ethnobotany will shape future global health policies, particularly in:
•​ Integrative medicine.
•​ Primary healthcare in rural and Indigenous communities
•​ Regulation of herbal medicines.
•​ Climate adapted health strategies.
       
Its evidence base will inform WHO guidelines, national pharmacopoeias and biodiversity governance frameworks.
 
New frontiers in drug discovery
 
Ethnobotany will remain a primary driver of natural product discovery, especially through:
•​ Cross cultural convergence analysis.
•​ Ethnopharmacological validation.
•​ Bioassay guided fractionation.
•​ AI assisted prediction of bioactive compounds
       
Future breakthroughs-akin to artemisinin, aspirin and quinine-will likely emerge from culturally salient species that have not yet been systematically investigated (drug discovery prospects).
 
Synthesis
 
The future of ethnobotany lies in its ability to bridge worlds: cultural and scientific, ecological and technological, traditional and modern. As herbal and natural product research becomes more interdisciplinary, ethnobotany will remain the foundational framework that ensures scientific innovation is grounded in cultural respect, ecological sustainability and ethical integrity.
 
Future directions
 
The future trajectory of ethnobotany positions it as an increasingly central, integrative and indispensable framework for herbal and natural product research. As scientific, cultural and ecological landscapes evolve, ethnobotany will expand its influence across discovery science, conservation policy and global health. Several key directions define its forward looking significance.
 
Deep integration with emerging scientific technologies
 
Ethnobotany will increasingly intersect with genomics, metabolomics, AI driven compound prediction and network pharmacology, enabling researchers to test culturally derived hypotheses with unprecedented analytical depth. These technologies will strengthen the link between traditional use patterns and molecular mechanisms, accelerating the identification of pharmacologically relevant species. This trajectory aligns with the growing field of ethnopharmacological innovation.
 
Expansion of biocultural conservation frameworks
 
Future conservation strategies will emphasise biocultural diversity, recognising that medicinal plant knowledge cannot be preserved without safeguarding the cultures, languages and ecosystems that sustain it. Ethnobotany will guide:
•​ Community based stewardship models
•​ Climate adaptive conservation planning
•​ Sustainable harvesting protocols
•​ Culturally grounded restoration programs
This direction strengthens the role of biocultural conservation in global biodiversity policy.
 
Ethical transformation of research practices
 
Ethnobotany will continue to shape ethical standards through:
•​ Prior informed consent
•​ Protection of traditional knowledge
•​ Equitable benefit sharing
•​ Co leadership with Indigenous communities
       
These frameworks will redefine natural product research as a collaborative, rights based enterprise, ensuring cultural respect and long term equity. This aligns with emerging models of ethical ethnobotany.
 
Development of global cross cultural databases
 
Future research will rely on large scale, digitally integrated cross cultural medicinal plant databases that combine:
•​ Ethnobotanical use records
•​ Linguistic data
•​ Ecological distributions
•​ Phytochemical profiles
•​ Pharmacological assays
       
Such platforms will enhance comparative analysis and reveal convergence patterns that guide drug discovery. This reflects the growing importance of cross cultural data systems.
 
Revitalisation and transmission of traditional knowledge
 
Ethnobotany will increasingly support:
•​ Cultural revitalisation initiatives
•​ Traditional healer networks
•​ Intergenerational knowledge transmission
•​ Community based education
       
These efforts will strengthen cultural resilience and ensure that medicinal plant knowledge continues to evolve within its cultural context.
 
Influence on global health and policy
 
Ethnobotany will shape future global health frameworks by informing:
•​ Integrative medicine policies
•​ Primary healthcare strategies in Indigenous and rural communities
•​ Regulation of herbal medicines
•​ Climate responsive health planning
       
Its evidence base will increasingly guide WHO recommendations and national pharmacopoeias, reinforcing its role in global health integration.
 
New horizons in drug discovery
 
Ethnobotany will remain a primary driver of natural product innovation. Future breakthroughs will emerge from:
•​ Cross cultural convergence analysis
•​ Bioassay guided fractionation
•​ AI assisted prediction of bioactive metabolites
•​ Re evaluation of under documented cultural pharmacopoeias
       
This direction underscores ethnobotany’s enduring relevance to drug discovery.
 
Synthesis
 
The future of ethnobotany lies in its ability to bridge cultural knowledge and scientific innovation, ensuring that natural product research remains ethically grounded, ecologically sustainable and culturally respectful. As global interest in herbal medicines continues to rise, ethnobotany will serve as the foundational framework guiding discovery, conservation and equitable collaboration.

Ethnobotany is not simply an entry point into the study of medicinal plants-it is the central interpretive framework through which plant selection, therapeutic meaning, cultural context and ecological relationships are understood. As a discipline, it integrates biocultural knowledge, phytochemical insight and ecological stewardship, allowing researchers to interpret medicinal plant use within the lived realities, worldviews and environmental adaptations of the communities who developed this knowledge. In an era of rapidly expanding global interest in natural medicines, ethnobotany remains indispensable for guiding responsible discovery, ensuring cultural respect and safeguarding biocultural heritage. Its methodologies and ethical principles help prevent extractive research, promote equitable benefit sharing and maintain the integrity of traditional knowledge systems (ethnobotany). As biodiversity and cultural diversity face unprecedented pressures, ethnobotany provides the conceptual and practical tools needed to link conservation, community rights and scientific innovation, ensuring that medicinal plant knowledge continues to thrive within the cultures that sustain it (biocultural heritage).

The present study was supported by my colleagues and students who suggested to complete it.
 
Disclaimers
 
The views and conclusions expressed in this article are solely those of the authors and do not represent the views of affiliated institution. The author is fully responsible for the accuracy and completeness of the information provided, but do not accept any liability for any direct or indirect losses resulting from the use of this content.

The author declares that there are no conflicts of interest regarding the publication of this article. No funding or sponsorship influenced the design of the study, data collection, analysis, decision to publish, or preparation of the manuscript.